Four Individuals Sentenced to Nearly 15 Years in Total After Major MHRA Probe into Illegal Online Medicine Supply

Four individuals associated with an organised criminal group have been sentenced at Wolverhampton Crown Court for their involvement in a significant operation that illegally supplied controlled substances, prescription-only medicines (POMs), and unlicensed medicinal products via the internet.

These sentences follow convictions that were obtained in November 2025, stemming from an extensive investigation carried out by the Medicines and Healthcare products Regulatory Agency’s (MHRA) Criminal Enforcement Unit (CEU).

Operation Lamborghini Uncovered Extensive Drug Trade

Operated under the name Operation Lamborghini, the investigation revealed a network responsible for the unlawful sale and distribution of medicinal products to customers throughout the UK. The group was linked to nearly two million doses of various medications, including Diazepam, Clonazepam, Lorazepam, Alprazolam, Codeine, Zolpidem, and Zopiclone, in addition to unapproved versions of medicines and illegally supplied POMs.

Dr Alison Cave, Chief Safety Officer at the MHRA, commented on the gravity of the situation, stating:

“Today’s sentencing underscores the severity of these offences and the substantial threat posed to public safety. This operation represented a sophisticated and lucrative criminal enterprise that exhibited a complete disregard for patient safety. Prescription-only medicines must only be obtained through a legitimate prescription issued by a qualified healthcare professional and dispensed by a registered pharmacy.”

Dr Cave further emphasised that “criminals engaged in the illegal sale of medicines endanger public health and erode trust in the healthcare system. I am immensely proud of my colleagues’ dedication and perseverance in ensuring that these offenders are brought to justice. We remain committed to identifying, disrupting, and prosecuting those involved in the illegal supply of medicines, employing all available measures to safeguard the public.”

Disregard for Public Health Highlighted in Sentencing

Gayle Ramsay from the Crown Prosecution Service remarked on the gravity of the offences, stating:

“The four defendants displayed a complete lack of concern for the health implications of selling unauthorised medicines and prescription-only drugs without proper medical consultation and authorisation. They were oblivious to the safety of these products and the potential ramifications for users. The sale of any illegal drugs can have devastating consequences for individuals and communities alike.”

The case was prosecuted by the CPS Serious Economic Organised and International Directorate (SEOCID), which highlighted that the defendants prioritised financial gain over patient safety, exposing the public to serious health risks. The medicines were supplied without the necessary clinical oversight or protective measures in place to safeguard patients.

Reporting Suspected Illegal Medicine Trading

Members of the public who suspect illegal trading in medicines or believe they may have encountered counterfeit products are encouraged to report their concerns directly to the MHRA Yellow Card scheme.

The sentences handed down were as follows:

• Everton Reynolds (DOB: 26/02/1967) – 5 years imprisonment
• Paul Billingham (DOB: 27/11/1968) – 4 years imprisonment
• Junior Ranger (DOB: 25/01/1981) – 2 years imprisonment (suspended for 18 months)
• Anita Rama (DOB: 12/05/1977) – 33 months (Class B and trademark) and 14 months concurrent (other offences)

Understanding the Role of the MHRA

Operation Lamborghini was a comprehensive investigation by the MHRA’s Criminal Enforcement Unit into the unlawful online distribution of controlled drugs, POMs, and unlicensed medicinal products. The CEU serves as the MHRA’s dedicated law enforcement arm, spearheading the agency’s efforts to combat medicine-related crime.

Its strategic objective is to protect the public, bolster confidence in regulatory practices, and uphold the rule of law by preventing and disrupting criminal activities while ensuring that offenders are brought to justice. The CEU utilises a wide array of capabilities, including intelligence analysis, online disruption, covert techniques, and asset recovery, collaborating closely with police and other law enforcement bodies both domestically and internationally.

The Medicines and Healthcare products Regulatory Agency (MHRA) is tasked with the regulation of all medicines and medical devices in the UK, ensuring their efficacy and safety. All actions undertaken by the agency are grounded in robust, evidence-based assessments to guarantee that the benefits of products outweigh any associated risks.

The MHRA operates as an executive agency of the Department of Health and Social Care.

For media inquiries, please contact newscentre@mhra.gov.uk, or call 020 3080 7651.